Epstein-Peterson ZD, Drill E, Aypar U, Batlevi CL, et al. Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation. Haematologica 2023 Aug 31. doi: 10.3324/haematol.2023.282898.
PMID: 37646671